Feifei Guan

Feifei Guan

Auto-generated profile, based on publicly available information

Feifei Guan

Biotecnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing, 10081, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
LRLiu Ren
Liu Ren
LMLina Men
Lina Men
ZZZhiwei Zhang
Zhiwei Zhang
FGFeifei Guan
Feifei Guan
JTJian Tian
Jian Tian
WZWei Zhang
Wei Zhang
Plastic polymers are widely used in agriculture, industry, and our daily life because of their convenient and economic properties. However, pollution caused by plastic polymers, especially polyethylene (PE), affects both animal and human health when they aggregate in the environment, as they are not easily degraded under natural conditions. In this study, Enterobacter sp. D1 was isolated from the guts of wax moth (Galleria mellonella). Microbial colonies formed around a PE film after 14 days of cultivation with D1. Roughness, depressions, and cracks were detected on the surface of the PE film by scanning electron microscopy (SEM) and atomic force microscopy (AFM). Fourier transform infrared spectroscopy (FTIR) showed the presence of carbonyl functional groups and ether groups on the PE film that was treated with D1. Liquid chromatography-tandem mass spectrometry (LC-MS) also revealed that the contents of certain alcohols, esters, and acids were increased as a result of the D1 treatment, indicating that oxidation reaction occurred on the surface of the PE film treated with D1 bacteria. These observations confirmed that D1 bacteria has an ability to degrade PE.

7 April 2023 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
ZDZundan Ding
Zundan Ding
GXGuoshun Xu
Guoshun Xu
RMRuiju Miao
Ruiju Miao
NWNingfeng Wu
Ningfeng Wu
WZWei Zhang
Wei Zhang
JTJian Tian
Jian Tian

1 March 2022 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
ZDZundan Ding
Zundan Ding
FGFeifei Guan
Feifei Guan
GXGuoshun Xu
Guoshun Xu
YWYuchen Wang
Yuchen Wang
YYYaru Yan
Yaru Yan
JTJian Tian
Jian Tian
• Gene sequence is the major factor contributing expression. • MPEPE is a mutation predictor for enhancing protein expression. • Identified mutations in enzymes increased its expression levels in E. coli.


1 April 2020 in Carbohydrate Polymers
Verified
Journal Article
Closed access
FGFeifei Guan
Feifei Guan
YHYanshuo Han
Yanshuo Han
KYKai Yan
Kai Yan
YZYan Zhang
Yan Zhang
ZZZhifang Zhang
Zhifang Zhang
JTJian Tian
Jian Tian

15 October 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
HGHan Gao
Han Gao
FGFeifei Guan
Feifei Guan
BLBoyu Luo
Boyu Luo
DZDongdong Zhang
Dongdong Zhang
WLWei Liu
Wei Liu
HHHuang Huoqing
Huang Huoqing
Deep learning models show promise in accelerating the design and optimization of antimicrobial peptides (AMPs), but current methods face challenges, such as low success rates, or large virtual library scales. In this study, we introduce DLFea4AMPGen, a bioactive peptide design strategy that leverages deep learning models to identify and extract key features associated with antimicrobial peptide activity. This approach enables the generation of peptide sequences with potential bioactivities. Using the SHapley Additive exPlanations (SHAP) method, we quantify the contribution of each amino acid in multifunctional peptides with potential antibacterial, antifungal, and antioxidant activities. Key feature fragments (KFFs) with the highest average contributions are extracted and classified into four subfamilies based on amino acid frequency. These high-frequency amino acids are systematically arranged to generate a plausible sequence subspace for candidate peptides, from which 16 representative sequences were selected for experimental validation. The results show that 75% (12/16) of the sequences exhibited at least two types of activity. Notably, D1 exhibits broad-spectrum antimicrobial activity, including efficacy against multidrug-resistant clinical pathogenic isolates both in vitro and in vivo. This proof-of-concept study underscores the potential of the DLFea4AMPGen platform for efficient design and screening of bioactive peptides, showcasing its value in AMP research.